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130 Prolonged survival in patients with resected non–small cell lung cancer and
single-level N2 disease
Steven M. Keller, MD, Mark G. Vangel, PhD, Henry Wagner, MD, Joan H. Schiller, MD,
Arnold Herskovic, MD, Ritsuko Komaki, MD, Randolph S. Marks, MD, Michael C. Perry, MD,
Robert B. Livingston, MD, and David H. Johnson, MD, for the Eastern Cooperative Oncology
Group, Bronx, NY; Boston, Mass; Tampa, Fla; Madison, Wis; Detroit, Mich; Houston, Tex;
Rochester, Minn; Columbia, Mo; Seattle, Wash; and Nashville, Tenn
After resection of single level N2 disease, median survival ranges from 27 to 40 months,
depending on the location of the primary tumor. Survival of patients with left upper lobe
tumors and N1 disease is similar to that of patients with N2 disease. Future modifications of
the TNM staging system should include the lobe of the primary tumor and the pattern of nodal
metastases.
138 Prevention, early detection, and management of complications after 328
consecutive extrapleural pneumonectomies
David J. Sugarbaker, MD, Michael T. Jaklitsch, MD, Raphael Bueno, MD,
William Richards, PhD, Jeanne Lukanich, MD, Steven J. Mentzer, MD, Yolonda Colson, MD, PhD,
Phillip Linden, MD, Michael Chang, MD, Leah Capalbo, BA, Elizabeth Oldread, MPH,
Siyamek Neragi-Miandoab, MD, Scott J. Swanson, MD, and Lambros S. Zellos, MD, MPH,
Boston, Mass, and New York, NY
We examined complications after extrapleural pneumonectomies between 1980 and 2000 to
refine surgical technique and develop detection and treatment algorithms for the most common
complications resulting in decreased physiologic effect, reduced mortality, and shorter hospital
stay. This strategy has permitted expansion of the operative criteria to include patients
previously deemed inoperable.
147 Tissue-engineered trachea from sheep marrow stromal cells with
transforming growth factor 2 released from biodegradable microspheres in
a nude rat recipient
Koji Kojima, MD, PhD, Ronald A. Ignotz, PhD, Toshihiro Kushibiki, MS, Kevin W. Tinsley, MA,
Yasuhiko Tabata, PhD, DMedSci, DPharm, and Charles A. Vacanti, MD, Worcester and
Boston, Mass, and Kyoto, Japan
The feasibility of using autologous sheep marrow stromal cells cultured onto polyglycolic acid
mesh to develop helical engineered cartilage equivalents of a functional tracheal replacement
was evaluated. We showed the potential benefit of local delivery of transforming growth factor
2 with biodegradable microspheres in a nude rat model.
Letters to the Editor 154 The effect of the dynamic air bubble trap on cerebral microemboli and
S100
Reza Motallebzadeh, MRCS, and Marjan Jahangiri, FRCS, London, United Kingdom
154 Improved pain control after cardiac surgery
Giuseppe Rescigno, MD, and Giannantonio Carnelos, MD, Reggio Emilia, Italy
155 Reply
Robert D. Dowling, MD, Louisville, Ky
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